Pharmaceutical companies are on an M&A spree that could break records this year as they look for novel drug and clinical-stage candidates to bolster the development pipeline.

Elon Musk may have recently given a big hint about what's on the horizon for SpaceX and Tesla.

Shares of Churchill Capital Corp XI are trading higher Monday morning following last week’s announcement of a definitive ...

Platform graduates from successful pilot with more than 1,500 accounts, 185,000 plays delivered, a 44% average clickthrough rate on artist profiles, and a 33% free-to-paid conversion rate ...

Patrick Industries (NASDAQ: PATK) (“Patrick”) and LCI Industries (NYSE: LCII) (“LCI” or “Lippert”) today announced they have entered into a definitive agreement to combine in an all-stock merger, ...

Economic success is not inevitable. It requires policies that encourage entrepreneurship, investment, innovation, and ...

AllianceBernstein trades near its 52-week low, offering an implied forward cash yield approaching 10%. See why I rate AB ...

Iconic is using AI to help Main Street business owners sell smarter as $5 trillion in small business value prepares to change ...

In what it described as a merger, Raleigh heavy building materials producer Martin Marietta said Monday it plans to buy ...

The US owner of Sky is to break itself in two, casting its British arm into the unpredictable maelstrom of media mergers being propelled by the decline of traditional television.

On Monday morning Comcast said it is spinning off NBCUniversal as well as its European media arm, Sky, into a new publicly ...